Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet

被引:44
作者
D'Souza, Gerard G. M. [2 ]
Weissig, Volkmar [1 ]
机构
[1] Midwestern Univ, Coll Pharm Glendale, Glendale, AZ 85308 USA
[2] Massachusetts Coll Pharm & Hlth Sci, Boston, MA 02115 USA
关键词
drug delivery; nanocarriers; subcellular targeting; BLOCK-COPOLYMER MICELLES; FOLATE-RECEPTOR; GENE DELIVERY; IN-VIVO; INTRACELLULAR DELIVERY; ALLOTOPIC EXPRESSION; DNA DELIVERY; LIPOPROTEIN NANOPLATFORM; DQASOME/DNA COMPLEXES; QUANTUM DOTS;
D O I
10.1517/17425240903236101
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability of a pharmacologically active molecule selectively to find its target. is closely linked with its potential as a successful therapeutic drug. It has become increasingly evident that there are several pharmacologically active molecules that exert their action on molecular targets inside cell organelles. In the case of a drug molecule with no defined specificity for a particular organelle, the molecule would either need to have sufficiently long metabolic stability to allow for random interaction with the organelle to occur, or a targeting strategy for the intended subcellular compartment would need to be devised in order to potentiate therapeutic effect. In the case of molecules with a stronger affinity for a non-target subcellular compartment, there exists even greater need for the ability to control subcellular disposition. Subcellular or organelle-specific targeting has thus emerged as a new frontier in drug delivery. In this review selected examples of recent work are discussed that the authors believe might eventually lead to the application of pharmaceutical nanocarriers to create the next generation of 'magic bullets' that are capable of delivering a drug payload to a molecular target at a subcellular location.
引用
收藏
页码:1135 / 1148
页数:14
相关论文
共 139 条
[71]   How can biochemical reactions within cells differ from those in test tubes? [J].
Minton, Allen P. .
JOURNAL OF CELL SCIENCE, 2006, 119 (14) :2863-2869
[72]   Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease [J].
Monroy, MA ;
Ross, FP ;
Teitelbaum, SL ;
Sands, MS .
BONE, 2002, 30 (02) :352-359
[73]   Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus [J].
Mudhakir, Diky ;
Harashima, Hideyoshi .
AAPS JOURNAL, 2009, 11 (01) :65-77
[74]   Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis [J].
Muro, S ;
Schuchman, EH ;
Muzykantov, VR .
MOLECULAR THERAPY, 2006, 13 (01) :135-141
[75]   Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers [J].
Muro, Silvia ;
Garnacho, Carmen ;
Champion, Julie A. ;
Leferovich, John ;
Gajewski, Christine ;
Schuchman, Edward H. ;
Mitragotri, Samir ;
Muzykantov, Vladimir R. .
MOLECULAR THERAPY, 2008, 16 (08) :1450-1458
[76]   Targeting lipophilic cations to mitochondria [J].
Murphy, Michael P. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2008, 1777 (7-8) :1028-1031
[77]   Targeting antioxidants to mitochondria by conjugation to lipophilic cations [J].
Murphy, Michael P. ;
Smith, Robin A. J. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 :629-656
[78]  
Nakai Kenta, 2007, V390, P429
[79]   Intracellular targeting of polymer-bound drugs for cancer chemotherapy [J].
Nori, A ;
Kopecek, J .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) :609-636
[80]  
Oca-Cossio J, 2003, GENETICS, V165, P707